Long‐Term Outcomes After Coronary Absorb BVS Implantation Guided by Intravascular Imaging
Catheterization and Cardiovascular Interventions · 10.11.2026
DOI: 10.1002/ccd.70950 ↗Kurz gefasst
Fachartikel in der Zeitschrift Catheterization and Cardiovascular Interventions, online erschienen am 10.11.2026. Verfasst von Costantino R Costantini und 8 weiteren Autor:innen. Beteiligte Einrichtung: Hospital Cardiologico Costantini, Instituto Francisco Costantini, Curitiba, Paraná, Brazil. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Coronary artery implantation of the absorb bioresorbable vascular scaffold (BVS) without intravascular imaging (IVI) guidance resulted in greater adverse events compared with metallic drug‐eluting stents during 3‐year follow‐up.
Aims
We assessed the 10‐year outcomes of BVS implanted with routine use of IVI guidance.
Methods
Between November 2014 and October 2016, 100 consecutive patients in whom the operator elected to implant a BVS were treated with 190 BVS devices in 171 lesions at a single center in Brazil. IVI was performed before and after BVS implantation in all patients. Clinical follow‐up was complete in all patients (no losses to follow‐up) for at least 8.8 years.
Results
Median follow‐up was 9.5 years (25th percentile 9.2, 75th percentile 10.1), range 8.8–10.8 years. Through the latest follow‐up, no patient experienced a cardiac death or definite scaffold thrombosis, and only one patient had a target‐vessel MI (TVMI). Major adverse cardiac events (the composite of all‐cause death, any MI, or any revascularization) occurred in 29 patients (Kaplan−Meier estimated 10‐year rate 29.4%); target vessel failure (TVF) (the composite of cardiac death, TVMI, or ischemia‐driven target‐vessel revascularization) occurred in 15 patients (10‐year rate 15.0%); and target lesion failure (the composite of cardiac death, TVMI, or ischemia‐driven target‐lesion revascularization) occurred in 10 patients (10‐year rate 10.0%). In the landmark analysis, TVF between 3 and 10 years occurred in 7 patients (7.6%).
Conclusions
In this single‐center, non‐randomized observational study, the long‐term outcomes of BVS implantation in simple and complex coronary lesions with routine IVI guidance were favorable. These findings are hypothesis‐generating and require confirmation in adequately powered randomized studies.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Hospital Cardiologico Costantini, Instituto Francisco Costantini, Curitiba, Paraná, Brazil.
- Icahn School of Medicine, Mount Sinai Hospital, New York, New York, USA.
ORCID-Profile: Sergio Gustavo Tarbine, Marcos Antonio Denk, Rafael M de Macedo, Gregg W Stone
Zitieren
APA
Costantini, C. R., Tarbine, S. G., Denk, M. A., Costantini, C. O., Ferrari, V. S., de Macedo, R. M., Luize, M. M., Dombeck, E. C., & Stone, G. W. (2026). Long‐Term Outcomes After Coronary Absorb BVS Implantation Guided by Intravascular Imaging. Catheterization and Cardiovascular Interventions. https://doi.org/10.1002/ccd.70950
Vancouver
Costantini CR, Tarbine SG, Denk MA, Costantini CO, Ferrari VS, de Macedo RM, et al. Long‐Term Outcomes After Coronary Absorb BVS Implantation Guided by Intravascular Imaging. Catheterization and Cardiovascular Interventions. 2026. doi:10.1002/ccd.70950
BibTeX
@article{Costantini2026,
author = {Costantini, Costantino R and Tarbine, Sergio Gustavo and Denk, Marcos Antonio and Costantini, Costantino O and Ferrari, Vinicius Shibata and de Macedo, Rafael M and Luize, Marcio Moreno and Dombeck, Everton C and Stone, Gregg W},
title = {Long‐Term Outcomes After Coronary Absorb BVS Implantation Guided by Intravascular Imaging},
journal = {Catheterization and Cardiovascular Interventions},
year = {2026},
doi = {10.1002/ccd.70950}
}
EUVIMED